Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

NEXICLON XR

CLONIDINE

Standard Dose
EQ 0.26MG BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: UNKNOWN Marketing status: Discontinued
Summary

Approval overview NEXICLON XR is listed in Drugs@FDA under application 022500 (NDA).

Review priority: UNKNOWN Marketing status: Discontinued Active ingredient CLONIDINE Form and strength TABLET, EXTENDED RELEASE;ORAL - EQ 0.26MG BASE Sponsor ROSEMONT Submission history Latest submission status date: 2010-09-23 00:00:00.

Structured Monograph

Clinical summary

Approval overview NEXICLON XR is listed in Drugs@FDA under application 022500 (NDA). Review priority: UNKNOWN Marketing status: Discontinued Active ingredient CLONIDINE Form and strength TABLET, EXTENDED RELEASE;ORAL - EQ 0.26MG BASE Sponsor ROSEMONT Submission history Latest submission status date: 2010-09-23 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: UNKNOWN

Interaction Notes

  • No interaction notes stored yet.